Co-infection with hepatitis a and leptospirosis in an adult with jaundice and acute febrile illness
Coinfección por hepatitis a y leptospirosis en un adulto con enfermedad febril aguda e ictericia
Article Sidebar
PDF (Español (España))
FLIP
HTML (Español (España))
EPUB (Español (España))
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Main Article Content
Abstract
Introduction: coinfection with hepatitis A and leptospirosis is a frequent cause of febrile jaundice syndrome in Colombia, characterized by fever, jaundice and findings compatible with acute hepatitis. Transmission of hepatitis A is by fecal-oral route while leptospirosis results from exposure to certain animals. Treatment of hepatitis A focuses on supportive measures while that of leptospirosis is based on prompt initiation of antibiotic therapy. Co-infection with the two entities is rare. Case presentation: patient who attended the emergency department with clinical and laboratory findings compatible with acute hepatitis A. After a torpid progression, an active search for other causes allowed finding a co-infection with leptospirosis. Discussion and conclusions: the abovementioned conditions were analyzed and a literature review was conducted. The few reports on this subject were discussed, highlighting this report for its contribution to global statistics and the importance of considering this diagnosis in the ER in a patient with a history of fever persisting for more than seven days, in order to reduce healthcare costs and to improve prognosis of patients.
Downloads
Article Details
References
Aggarwal R, Goel A. Hepatitis A: Epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28(5):488-96. https://doi.org/10.1097/QCO.0000000000000188. DOI: https://doi.org/10.1097/QCO.0000000000000188
Lin KY, Chen GJ, Lee YL, Huang YC, Cheng A, Sun HY, et al. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J Gastroenterol. 2017;23(20):3589-606. https://doi.org/10.3748/wjg.v23.i20.3589 DOI: https://doi.org/10.3748/wjg.v23.i20.3589
Cortés JA, Romero Moreno LF, Aguirre León CA, Pinzón Lozano L, Cuervo SI. Enfoque clínico del síndrome febril agudo en Colombia. Infectio. 2016;21(1):39-50. doi: http://dx.doi.org/10.1016/j.infect.2015.11.005 DOI: https://doi.org/10.22354/in.v21i1.640
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015;9(9):0-1. https://doi.org/10.1371/journal.pntd.0003898. DOI: https://doi.org/10.1371/journal.pntd.0003898
Haake DA, Levett PN. Leptospirosis in Humans. En: Adler B, Editor. Leptospira and Leptospirosis. Berlin, Heidelberg. Springer; 2015. p. 65-97. https://doi.org/10.1007/978-3-662-45059-8. DOI: https://doi.org/10.1007/978-3-662-45059-8_5
Venkatesh S. National guidelines for diagnosis & management of viral Hepatitis. Natl Heal Mission. 2018. p. 80.
Samrot, A.V et. al. Leptospiral Infection, Pathogenesis and Its Diagnosis—A Review. Pathogens. 2021;10(2):145. https://doi.org/10.3390/pathogens10020145. DOI: https://doi.org/10.3390/pathogens10020145
Instituto Nacional de Salud. Informe de evento Hepatitis A en Colombia para el año 2019. 2019. p.3.
Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2018;68(1):167-84. https://doi.org/10.1016/j.jhep.2017.08.034. DOI: https://doi.org/10.1016/j.jhep.2017.08.034
Instituto Nacional de Salud. Protocolo de vigilancia en Salud Pública. Leptospirosis. Código 455 [Internet]. Inst Nac Salud Colomb Minist Salud. 2017 [consultado 2020]. Disponible en: https://www.ins.gov.co/buscador-eventos/Lineamientos/Pro_Leptospirosis.pdf
SIVIGILA. Informe del evento Leptospira para el año 2019 en Colombia. Instituto Nacional de Salud. 2019.
Castroa L, Leyla Nazala, Guillermo Silvaa, Javier Brahma, Roberto Segoviaa, Mario Ferrariob, Erwin Buckelb, Mario Uribeb, Felipe Puelmab, Tomás Regueirac, Recciuscd A, Fardellae P, Rodrígueze de los MÁ. Manejo de la falla hepática fulminante: propuesta de protocolo en Clínica Las Condes. Rev Méd Clín Condes. 2019;30(2):191-205. https://doi.org/10.1016/j.rmclc.2019.03.003. DOI: https://doi.org/10.1016/j.rmclc.2019.03.003
Syhavong B, Rasachack B, Smythe L, Rolain JM, Roque-Afonso AM, Jenjaroen K, et al. The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Trans R Soc Trop Med Hyg. 2010;104(7):475-83. https://doi.org/10.1016/j.trstmh.2010.03.002 DOI: https://doi.org/10.1016/j.trstmh.2010.03.002
Sethi S, Sharma N, Kakkar N, Taneja J, Chatterjee SS, Banga SS, et al. Increasing trends of leptospirosis in Northern India: A clinico-epidemiological study. PLoS Negl Trop Dis. 2010;4(1):e579. doi: https://doi.org/10.1371/journal.pntd.0000579 DOI: https://doi.org/10.1371/journal.pntd.0000579
Alves AP, Moura Silva DC, Spolti GP. Co-infection with hepatitis A and leptospirosis in the Amazon region: report of two cases. Trop Gastroenterol. 2011;32(3):234-6.